The new ACMG statement on “Noninvasive Prenatal Screening” addresses: The current limitations of NIPS; the advantages of NIPS compared with current screening approaches; pretest and posttest genetic counseling; the reporting of results by laboratories performing NIPS; and the oversight of analytical and bioinformatic components by testing of the laboratories performing NIPS.